Is Monopar Therapeutics a good buy right now?
USNASDAQ: MNPRNASDAQ-listedlast $95.31 · 21 Sep 2026
Not yet — wait
Signal paused. MNPR's price history has a jump — most likely a split or bonus issue that was not adjusted — and 7 trades touching it were left out until the data is checked. The last Buy signal came on 10 Jul 2026 at $101.4 and closed on 21 Sep 2026 (−6.0%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 9 buy signals on MNPR
Oct 2024 – 30 Sep 20262 of 9 closed above the entry price, with an average outcome of +0.6% per signal before costs; a signal typically stayed open about 4 d. 7 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 10 Jul 2026 | $101.4 | 21 Sep 2026 | 10 wk | -6.0% |
| 22 Jun 2026 | $70.34 | 9 Jul 2026 | 2 wk | +58.3% |
| 18 Sep 2025 | $61.64 | 2 Oct 2025 | 2 wk | +50.9% |
| 17 Sep 2025 | $67.18 | 17 Sep 2025 | 1 d | -15.7% |
| 29 Jan 2025 | $41.03 | 25 Feb 2025 | 4 wk | -21.3% |
| 28 Jan 2025 | $41.77 | 28 Jan 2025 | 1 d | -14.2% |
| 23 Jan 2025 | $39.5 | 27 Jan 2025 | 4 d | -18.3% |
| 8 Oct 2024 | $5.6 | 9 Oct 2024 | 1 d | -10.2% |
| 1 Oct 2024 | $6.14 | 1 Oct 2024 | 1 d | -18.2% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 22% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about MNPR
MNPR share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Monopar Therapeutics. Signal paused. MNPR's price history has a jump — most likely a split or bonus issue that was not adjusted — and 7 trades touching it were left out until the data is checked. The last Buy signal came on 10 Jul 2026 at $101.4 and closed on 21 Sep 2026 (−6.0%). The last price on record was $95.31 on 21 Sep 2026.
How has Firefly's strategy done on Monopar Therapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 9 buy signals on Monopar Therapeutics; 2 closed above the entry price and the average outcome was +0.6% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Monopar Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Monopar Therapeutics and how it turned out is listed on this page.
Should I sell Monopar Therapeutics?
No sell trigger is active on Monopar Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →